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Abstract 
 
Purpose 
To explore the perceived and potential roles of pharmacists in the care of young people aged 10-
24 years with chronic illness, through the exemplar of juvenile arthritis, from the perspectives of 
UK community and hospital pharmacists, health service commissioners, rheumatology health 
professionals and lay advocates. 
Methods 
A sequential mixed methods study design comprising: focus groups with community and 
hospital pharmacists; telephone interviews with pharmacy and rheumatology stakeholders and 
commissioners, and multidisciplinary group discussions to prioritize roles generated by the first 
two qualitative phases. 
Results 
The high priority roles for pharmacists, identified by pharmacists and rheumatology staff, were: 
developing generic healthcare skills among young people; transferring information effectively 
across care interfaces; building trusting relationships with young people; helping young people to 
find credible online health information, and the need to develop specialist expertise. Participants 
identified associated challenges for pharmacists in supporting young people with chronic illness. 
These challenges included parents collecting prescription refills alone, thus reducing 
opportunities to engage, and pharmacist isolation from the wider healthcare team.  
Conclusions 
This study has led to the identification of specific enhancements to pharmacy services for young 
people which have received the endorsement of a wide range of stakeholders. These suggestions 
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could inform the next steps in developing the contribution of community and hospital pharmacy 
to support young people with chronic illness in the optimal use of their medication. 
 
 
Keywords 
Chronic disease; pharmacy; adolescent; young adult; transition to adult care; medication therapy 
management; juvenile arthritis; rheumatology; community pharmacy services; hospital pharmacy 
service. 
 
Implications and Contribution 
The role of community/retail and hospital pharmacists in the care of young people with chronic 
illness could be further developed to complement the role of other healthcare providers. Research 
in this area has been scarce. Priority roles, and associated challenges, are identified by 
stakeholders within and beyond pharmacy. 
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The role of the pharmacist as a member of the adolescent health team, particularly in the care of 
young people with chronic illness, has not been widely researched. The two main employment 
groups are community pharmacists (sometimes called ‘retail pharmacists’) and hospital 
pharmacists. In this paper, there will be reference to ‘pharmacists’ as a professional group across 
the two settings; in some places it will be necessary to differentiate between the two 
environments. There are good reasons to consider the engagement of pharmacists in adolescent 
medication use. In developed countries, transcending the way that health systems and medication 
supply are financed, the vast majority of prescriptions for medication for young people will have 
been reviewed, checked and/or dispensed by a pharmacist. Woods et al.1 undertook secondary 
analysis of adolescent data from a large medical care dataset in Colorado and Utah. Medication-
related events were the second most frequent source of safety problems, and the highest 
incidence of patient safety issues occurred in the pharmacy setting.  
 
The role of the community pharmacist in reproductive and public health has attracted more 
research. Emergency contraception studies noted that young women have found the profession to 
compare well to other reproductive health providers - accessibility and non-judgmental attitude 
were positively cited2, and 94% of adolescents said they would recommend the service to a 
friend3. Studies have also, however, highlighted the potential for community pharmacists to 
break confidentiality – when, for example, pharmacists might contact a parent before dispensing 
contraception to minors4. In relation to vaccination, there has been recognition of the potential of 
the community pharmacy setting as a ‘unique resource’ to increase adolescent immunization 
rates5 – but the need to increase pharmacists’ experience with young people was noted. 
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Pharmacists report a lack of training and confidence in engaging with young people4. 
Community pharmacy staff are unsure whether their adult-focused services should be offered to 
young people, especially those aged under 16 years6. UK pharmacists may, however, be gaining 
confidence from providing public health services to young people. In a small study, almost two-
thirds (62.2%) of the 143 community pharmacists surveyed felt ‘reasonably confident’ about 
engaging with young people, and almost another third (30.1%) felt ‘very confident’7. Increasing 
numbers of community pharmacists internationally now provide commissioned services to 
discuss medication with patients. The most commonly used overarching term to describe these 
cognitive, patient-centered services that go beyond the supply function is ‘pharmaceutical care’8, 
but other country-specific terms include ‘medication therapy management’ (US) and ‘medicines 
optimization’ (England). A study of UK community pharmacists reported significant self-
reported engagement with young people7. Whilst approximately half of these pharmacists 
reported dispensing prescriptions ‘often’ and providing public health services ‘often’ for young 
people aged 13-19 years (53.8% and 45.4% respectively), only 5.2% reported chronic medication 
review activities ‘often’ with this age group.  
 
The aim of this study was to explore the perceived and potential roles of pharmacists in the care 
of young people with chronic illness, through the exemplar of juvenile arthritis, from the 
perspectives of UK community and hospital pharmacists, rheumatology health professionals and 
health service commissioners (payers). 
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The WHO age range for young people of 10-24 years was adopted in this research in order to 
reflect the range of important biological, cognitive, psychosocial and vocational transitions that 
can impact on the use of medication9. 
 
Methods 
An overview of the project methods is provided in Table 1. A blog-based project called 
‘Arthriting’ was undertaken by the authors in 2012/13 to elicit the views of young people 
attending a rheumatology service aged 11-19 years, and their parents/caregivers, about the links 
between identity, the arthritis condition and medication10-12. This subsequent project would 
challenge pharmacists with the ‘Arthriting’ data to think how they could better engage with, and 
support, young people with chronic illness and their families. 
 
The sequential mixed methods study design13 allowed stakeholders to identify, and then 
prioritize, current and future roles that would underpin the pharmacist’s contribution to the care 
of young people with chronic illness. The first two phases – pharmacist focus groups and 
stakeholder telephone interviews - were qualitative, reflecting the dearth of literature in this area 
and the need to capture and record ideas from pharmacists and stakeholders about current and 
future roles that would support young people and families. The final phase – multidisciplinary 
discussion groups - was quantitative, encouraging pharmacists and rheumatology professionals 
to discriminate between ideas and to prioritize roles to be developed or enhanced. Each phase 
had a particular objective within the aim of the overall study. 
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Institutional ethical approval for the study was given by Aston University Health and Life 
Sciences Research Ethics Committee. 
 
Recruitment of Participants 
A number of recruitment strategies were employed to recruit pharmacists to Phases 1 and 3, 
through gatekeepers in the Royal Pharmaceutical Society (RPS) - the national professional body 
for pharmacy, the national continuing education organizations in England and Wales, and the 
NHS regions surrounding the group venue in Scotland. The RPS does not represent all 
pharmacists – during the recruitment period 54% of all licensed pharmacists in Great Britain 
were members. It is, however, the national professional forum and that was deemed appropriate 
for recruiting pharmacists for this work. The continuing education organization and NHS mailing 
lists, however, do include most registered community and hospital pharmacists. We aimed for 
maximum diversity sampling to reflect different pharmacist characteristics in terms of length of 
time in practice, role in practice and practice setting. Administrators sent out an initial email 
asking for expressions of interest. Interested pharmacists were asked to reply direct to the project 
manager (NJG). An article was placed in the ‘Pharmaceutical Journal’, which was the weekly 
professional publication sent to all members of the Royal Pharmaceutical Society. The inclusion 
criterion was to be a practicing community or hospital pharmacist who could travel to the group 
venue on the advertised date – there were no exclusion criteria. 
 
A list of stakeholders for telephone interviews in Phase 2 was generated by advisory group 
members and the project team. Inclusion criteria were participation at a senior level in a 
pharmacy or rheumatology organization. An email was sent to each suggested stakeholder, 
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including an outline of the interview study and an invitation to reply if they would like more 
information; one follow-up email was sent 7 days later. The study was also advertised by email 
to all members of the Barbara Ansell National Network for Adolescent Rheumatology 
(BANNAR) http://bannar.org.uk/ . BANNAR includes the majority of adolescent/young adult 
focused rheumatologists in the UK, including both pediatric and adult multidisciplinary 
rheumatology professionals. 
 
To recruit rheumatology staff in Phase 3 an email was sent to a facilitator in each of three 
hospital pediatric rheumatology centers for whom we had a contact among the project team 
and/or advisory group members. There are 15 similar training centers across the UK; the 
population served by these centers reflected their local communities well. The multidisciplinary 
rheumatology team members invited included doctors, clinical nurse specialists, occupational 
therapists, physiotherapists and transition coordinators. Again we aimed for maximum diversity 
within the targeted team to include different roles and length of experience. 
 
All phases involved obtaining informed written consent from participants. All participants were 
offered a modest honorarium for their contribution. Travel expenses were offered in Phases 1 
and 3. Locum backfill payments were offered to community pharmacists for Phase 3 as the 
groups were conducted during pharmacy opening hours. 
 
Research Settings 
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Phase 1 pharmacist focus groups were convened in the evening, scheduled for 90 minutes. The 
venues were also used for local pharmacy group meetings, thus familiar to participants. All four 
focus groups were facilitated by the project manager (NJG). 
 
Phase 3 multidisciplinary discussion groups were convened at the targeted pediatric 
rheumatology centers across England and Scotland, and scheduled during a time dedicated to a 
regular weekly continuing medical education session for the multidisciplinary team. Hospital 
pharmacists, who would not normally have been included in those sessions, joined the 
rheumatology team from their base on-site. Community pharmacists travelled to the center to 
join the session.  
 
Discussion and Interview guides 
The Phase 1 topic guide included pharmacists’ experience of engaging with young people about 
medication use and adherence; pharmacists’ experience of engaging with specialist teams in 
hospital, including rheumatology, and their perception of current and future roles in the care of 
young people with chronic illnesses.  
 
Phase 2 stakeholders were sent a briefing before the interview to give them background 
information and prompts which would guide the interview. It combined ‘Arthriting’ blog quotes, 
some innovative pharmacist case studies, and an interim analysis of the Phase 1 focus groups. 
The telephone interview schedule was tailored to the role of the interviewee, including 
rheumatology team members’ experience of engaging with hospital and/or community 
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pharmacists about young people (positive or negative), and commissioners’/payers’ views about 
pharmacists’ potential to support young people taking medication. 
 
A quantitative approach was applied to the Phase 3 discussions, adopting techniques of 
prioritization and sorting deployed in nominal groups14. A consensus-building tool for a previous 
study15 was adapted to provide a structured format for paper-based prioritization exercises. Small 
multidisciplinary groups of 2-3 people undertook a paper-based exercise where they assigned a 
ranking (1-5, where 1 is low) to current or potential pharmacy roles. 
 
Pharmacists and rheumatology staff attending the Phase 1 and 3 groups noted their demographic 
details on a structured pro-forma, before the session began, to help the team to monitor diversity. 
 
Data Analysis 
Data analysis in this project was dynamic, as each phase built upon the previous one to prioritize 
best practice development roles for pharmacists to better support young people and families. 
 
Qualitative Data Analysis (Phases 1 and 2) 
Phase 1 focus group discussions and Phase 2 telephone interviews were recorded on digital 
audio, which were transcribed verbatim, checked, and identifiers (names of people or places) 
were removed. A ‘middle-order’ thematic approach16 was used, which is consistent with 
‘directed content analysis’17. The study objectives provided a source of categories with which to 
organize participants’ responses, whilst allowing other themes to emerge.  
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Issues of rigor and bias were anticipated and addressed within the qualitative work. In Phase 1, 
three clinicians on the team (JB, JMcD, DT) and the project manager (NJG) each listed all the 
current and future pharmacy roles contained in one focus group transcript. NJG then compiled a 
list of the most commonly cited roles to underpin the Phase 2 interview briefing; roles cited in 3-
4 of the groups were included. A framework approach was employed for the analysis of Phase 2 
interviews18. Each respondent had chosen their priority pharmacy roles. The responses were 
summarized by one of the interviewers (EP), and were independently reviewed by the project 
manager (NJG). Where Phase 2 stakeholders validated and supported pharmacy roles, this helped 
to confirm the list of roles to be scored in Phase 3. Consistency within and between phases was 
monitored to assess the trustworthiness of the findings. 
 
Quantitative Data Analysis (Phase 3) 
Phase 3 data were transcribed from paper data collection forms to an Excel™ spreadsheet. The 
analysis of data from the final discussion groups was basic descriptive statistical analysis of 
quantitative ranking (tables of frequencies). The mean rank for the score achieved for each 
pharmacy role was calculated. 
 
Triangulation 
Triangulation of data took place at two key milestones during the study. At the end of Phase 2, 
the data from both qualitative phases were compared to finalize the possible roles that would be 
incorporated into the Phase 3 prioritization materials. Following the analysis of the quantitative 
Phase 3 prioritization data, we returned to the qualitative data to provide context and illustration 
for the themes corresponding to the highest priority roles. 
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Results 
Table 1 describes the participants in this study. There was diversity of setting, experience and 
role among pharmacists in the study. The focus groups took place in two large cities, one small 
city with rural outskirts and one small town. In Phase 1 focus groups, for example, the 9 
community pharmacists reported their main settings as village (n=5), suburban high street (n=3) 
and local neighborhood shops (n=1). The 7 hospital pharmacists who provided data on their 
hospital type classified them as large (n=4), medium (n=1) and small (n=2). Three of the 9 
participating hospital pharmacists were not based in pediatric institutions. Roles ranged from 
newly qualified pharmacists in their first managerial role through to chief pharmacists of large 
teaching hospitals. 
 
[Table 1 goes about here] 
 
In Phase 3 there was similar diversity of setting and experience among the pharmacy attendees. 
Rheumatology staff provided multidisciplinary input from physicians, nurses and a 
physiotherapist. Inevitably these specialist centers were based in three large cities, but 
community pharmacists travelled in from surrounding suburban and village settings to take part. 
 
Table 2 reports the prioritization of pharmacy roles by Phase 3 participants, which represent the 
study priorities for community pharmacy service development.  
 
[Table 2 goes about here] 
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In this section we present qualitative data from Phases 1 and 2 that complement the highest 
priority roles from Phase 3 results: developing generic healthcare skills among young people; 
transferring information across care interfaces to support clinical care; building trusting 
relationships with young people and their families; helping young people to find credible online 
information about health and medication, and the need to develop specialist expertise. 
 
Pharmacist support of the development of generic healthcare skills among young people (such as 
getting a prescription refill and minimizing co-payments) received the highest prioritization. This 
was a strong theme across the study phases, reflected by pharmacists and rheumatology 
stakeholders alike: 
It may be the first time that these young people are using healthcare and we need to make 
sure that they’re using it effectively. And so it’s a really key critical time and using a 
pharmacy and taking advice from pharmacists etc. is an important thing for them for the 
future. So it’s trying to encourage that, I guess, as much as possible. 
[SK30 – Rheumatologist, Phase 2] 
 
The need for routine information transfer from the specialty hospital team to the community 
pharmacist was also a high priority. Hospital pharmacists reflected on the need for better routine 
communication with community pharmacy colleagues, and the challenge to incorporate that into 
their daily activities: 
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P14: But as community pharmacists, presumably you get all of your information via the 
GP [primary care doctor] and the patient, don’t you?  We as hospital pharmacists don’t 
routinely communicate with community pharmacists, do we? In terms of discharge. 
P15: And it’s a pity, because we should be doing it, but there’s just no time in the day.  
[Hospital Pharmacists, Phase 1] 
 
Building long-term relationships with young people was seen as a priority. Community 
pharmacists considered it difficult to engage young people with chronic illness as their parents 
tended to collect the prescriptions on their own: 
We have a few [young people] with long-term conditions, but mainly their parents will 
come. We have got some that have got heart conditions, and they’re not likely to come 
often. They may come once in a while, but mainly the parents will come instead of them. 
[P05 – Community Pharmacist, Phase 1] 
 
The collection of medication by unaccompanied minors was largely discouraged in both 
community and hospital settings; participants reflected that this approach could be changed to 
encourage empowerment and engagement: 
I sometimes think we don’t help ourselves…We have a notice up that says ‘Children 
under 16 are not allowed to collect medicines’, as opposed to putting it in a different 
way: ‘If you are under 16, and you would like to collect your medicine, please talk to us’.   
[P14 - Hospital Pharmacist, Phase 1] 
 
The role of pharmacists in caring for young people with chronic illness 
17 
Some participants identified the potential to build a relationship over a number of years and to 
see young people taking more responsibility for medication during adolescence: 
We've got a few type 1 diabetics… When they're young - when they are ten or younger, 
their parents do everything for them…We are there all the time, we see them grow 
up…And then as they grew up through the teenage years, they take more responsibility 
and they come in and sometimes they want it, they don’t want it, and they are very 
articulate about what they want. [P12 – Community Pharmacist, Phase 1] 
 
In Phase 3, many participants supported pharmacists sharing websites and apps that could help 
young people to manage chronic illness. A number of community pharmacists in Phase 1 talked 
about technology underpinning their engagement with young people. One community 
pharmacist, for example, reported enquiries from young people inspired by information-seeking 
on the Internet: 
Younger people…say ‘We found something on the internet’, or sometimes they show me 
something they found online… [They ask] ‘What do you think from this?’ or ‘Is this true?’ 
and different things like that…Just little bits that you wouldn’t really get with any other 
age group, apart from the youngsters really. [P06 – Community Pharmacist, Phase 1] 
 
The integration of the hospital pharmacist into the multidisciplinary specialty team was 
prioritized in Phase 3. Many young people with chronic illnesses like arthritis are seen in hospital 
outpatient clinics rather than inpatient wards. The pharmacist is not traditionally involved in 
these clinics beyond the dispensing task, but there was openness to include them: 
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We have a multidisciplinary team meeting every week, which everyone from social workers 
to our nurses, to the physio, OT, some of the nursing staff on the wards…And again 
pharmacy would be very welcome to attend if they wished to; in our hospital it would 
probably be a good place to start with interactions. [SK54 – Rheumatologist, Phase 2] 
 
Other rheumatologists described innovation with pharmacists. One center had a pharmacist 
prescribing methotrexate in clinic. Another team had a dedicated pharmacist attached to their 
group, who answered the specialty team’s queries but did not attend clinic.  
 
Phase 3 participants prioritized the development of specialist expertise among pharmacists for 
chronic illnesses. Hospital pharmacists may do this; in recent years some have been employed 
directly by specialist teams. Whether it was reasonable for a generalist practitioner like a 
community pharmacist to embrace the specialty knowledge for all pediatric conditions was also 
discussed: 
I do sympathize with a pharmacist who is working in the community and has a huge 
range of things that they need to be involved with and to be aware of…I think when 
you’re talking about a very small population of people who are taking things like 
methotrexate in childhood, I think it’s very hard for someone to keep abreast of all of 
that. [SK26 – Rheumatologist, Phase 2] 
 
Discussion 
This study identified a diverse range of potential opportunities, and clear priorities, to guide 
service developments to support pharmaceutical care for young people with chronic illness. The 
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high priority roles identified by pharmacists and rheumatology staff were: developing generic 
healthcare skills among young people; transferring information across care interfaces; building 
trusting relationships with young people; helping young people to find credible online health 
information, and the need to develop specialist expertise. The support offered must be sensitive 
to the multiple physical, emotional and social transitions experienced by young people aged 10-
24, tailored to each individual.  
 
It is relatively easy to develop pharmacy public health roles because the activities can be 
exercised independently of other professionals; a role in chronic illness management cannot be 
exercised in isolation. For juvenile arthritis, the rheumatology team may include doctors, nurses, 
physiotherapists, occupational therapists and transition-focused personnel. Primary care doctors 
will also play a role. A review of the case notes of 150 young people aged 11-18 attending the 
rheumatology service at a large UK pediatric hospital showed that pharmacy involvement was 
not being recorded19. The blog-based ‘Arthriting’ study revealed few references to pharmacists 
among the accounts from young people and parents10. Moreover, during the ‘Arthriting’ 
research, a scoping review of the literature was undertaken to determine the contribution of 
pharmacists to the care of young people with three exemplar chronic illnesses (juvenile arthritis, 
insulin-dependent diabetes mellitus IDDM and inflammatory bowel disease IBD)10. There was 
only one account of a pharmacist-directed peer support program for six young people with 
IDDM in the USA20 – pharmacy initiatives are not widespread for this age group.  
 
Juvenile arthritis has a prevalence similar to type I diabetes, affecting 1 in 1,000 children and 
young people in the UK21 with active disease that continues for a significant number into 
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adulthood, and is thus a useful exemplar for a range of chronic illnesses. Whilst each clinical 
condition will have its own features and challenges, chronic illnesses have common 
characteristics22. Community pharmacists are generalists, and many hospital pharmacists have to 
operate across a number of clinical specialties, so this ‘non-categorical’ approach23 can enable 
the profession to engage with generic chronic illness issues during adolescence. All pharmacists 
must, however, possess enough specialist knowledge to ensure medication use is safe for all 
patients. There are a number of medication-related issues that particularly concern young people, 
such as interactions with alcohol and other drugs, and side-effects24. Pharmacists will need to 
recognize these issues and be ready to offer relevant advice about medication dispensed for 
young people. We would expect the principles of young people friendly services25 to apply 
across chronic illnesses, and that young people’s priorities regarding services - and the nature of 
their consultations with pharmacists - are also likely to be similar. It therefore seems reasonable 
to take insights from juvenile arthritis to inform the pharmacy contribution to the care of young 
people with a wide range of chronic illnesses.  
 
Young people may be more open to using the pharmacist as a health information channel than 
adults. A 2014 survey of 4,182 consumers across France, Germany, Portugal and the UK 
reported that respondents aged 24 and younger were more likely than other age groups to 
consider pharmacists a trustworthy source of information26. Many young people are very 
engaged in self-management in the home, but withdraw when they are in a medical setting27; 
pharmacists based in a familiar retail setting may be able to recognize and foster the partnerships 
between young people and parents. They could also have a role in supporting young people 
through transition, as a constant and accessible source of advice when other services are 
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changing. Recent work in the UK has confirmed that the ‘You’re Welcome’ youth-friendly 
service criteria can be applied directly to the community pharmacy setting28. To realize these 
aspirations, the training of pharmacists will have to include resources about providing 
developmentally appropriate care to young people, including physical and cognitive 
development.  
 
This project was successful in engaging a broad range of participants across the UK. The present 
project was built on the findings from the previous ‘Arthriting’ study10, using ‘Arthriting’ data – 
direct blog quotes from young people and parents - as the stimulus. Both internal and external 
views of the pharmacy profession were considered to develop a vision of pharmacy care for 
young people with chronic illness. There was enthusiasm and interest in the topic from the 
pharmacy and rheumatology stakeholders. We acknowledge the limitations of the project, 
however. A relatively small number of participants were involved. Participants may have had a 
specific interest - and possible bias - for the topic of young people’s health and/or arthritis, but 
this underscores their frank admission of the challenges to better engagement. Not all 
multidisciplinary groups in Phase 3 completed the ranking for all roles in the time available. 
 
Pharmacists have not hitherto been visible in the care of young people with chronic illnesses. If 
pharmacists wish to develop long-term therapeutic relationships with young people who have 
chronic illnesses, there may be untapped goodwill within the multidisciplinary care team. This 
study has led to the identification of specific enhancements to pharmacy services for young 
people which have received the endorsement of a wide range of stakeholders. Inevitably any 
change in practice will start with pharmacists who develop skills and interest in better care for 
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young people; hopefully a critical mass will then start a ‘ripple effect’ of normalization through 
to the wider pharmacist population. These prioritized roles could inform the next steps in 
developing the contribution of community and hospital pharmacy to support young people with 
chronic illness in the optimal use of their medication. 
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Table 1: Project Design 
 
Study Phase Phase 1 –  
Pharmacist Focus Groups 
Phase 2 –  
Stakeholder Interviews 
Phase 3 – Multidisciplinary  
Discussion Groups 
Fieldwork Period September – October 2014 
 
November 2014 – April 2015 February – March 2015 
Fieldwork 
Objective 
To elicit the experiences and opinions of a 
diverse group of practising hospital and 
community pharmacists about their 
engagement with young people who take 
medication for chronic illness 
 
To share the ideas of practising pharmacists 
about their current and future roles in the 
support of young people who take 
medication for chronic illness with 
stakeholders in order to devise a list of 
roles for prioritization 
To submit a list of possible best practice 
roles for community and hospital 
pharmacists to the critical reflection and 
prioritization of multidisciplinary groups of 
pharmacists and rheumatology 
professionals 
Fieldwork Features  4 Focus groups 
 9 community and 9 hospital 
pharmacists 
 Direct quotes from the Arthriting 
project10 used as stimulus points 
 Participants from England, Scotland 
and Wales 
 90-minute duration 
 15 Telephone interviews 
 2 pharmacy policymakers, 3 service 
commissioners, 2 pharmacy staff 
members, 5 rheumatology 
professionals and 3 lay advocates 
 Direct quotes from the Arthriting 
project10 used as stimulus points 
 Participants from England, Scotland 
and Northern Ireland 
 20-minute duration 
 
 3 Discussion groups 
 9 community pharmacists, 4 hospital 
pharmacists, 7 rheumatology 
physicians, 5 specialist nurses, and 1 
physiotherapist 
 Direct quotes from the Arthriting 
project10 used as stimulus points 
 Participants from England and Scotland 
 90-minute duration 
Data Collected  Demographic participant data 
 Verbatim transcripts 
 Verbatim transcripts 
 Prioritisation of issues affecting 
adherence and affecting pharmacy 
engagement 
 Demographic participant data 
 Attitude statements 
 Prioritisation of pharmacy roles and 
skill developments 
 
Priority-Setting 
Output 
Briefing for Phase 2 stakeholder interviews Statements for Phase 3 group participants 
to prioritize (consolidated with Phase 1 
data) 
Consensual prioritization of roles to inform 
study recommendations 
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Table 2 – Results of the role prioritization activity in multidisciplinary discussion groups 
 
Current / Future Role Priority Score 
Community pharmacists help young people to develop their general healthcare skills e.g. 
prescription refills, getting free prescriptions. 
4.78 
Information supplied by hospital pharmacists at discharge goes directly to a nominated 
community pharmacist as well as the GP. 
4.71 b 
Community pharmacists can build long-term relationships with young people and families. 4.71 b 
Pharmacists share information with young people about apps and websites that support 
adherence and give information about JIA. 
4.57 b 
Hospital pharmacists are included in MDT sessions for rheumatology patients. 4.44 
Pharmacists develop specialist expertise in pediatric/adolescent rheumatology. 4.44 
Pharmacists develop specialist expertise in young people’s medication use for other long-
term conditions (asthma, diabetes). 
4.44 
Pharmacists provide educational sessions for the multidisciplinary rheumatology team about 
medicines optimization. 
4.43 b 
Community pharmacists can support young people and families in medication-taking. 4.33 
Pharmacists facilitate young people’s self-advocacy skills (e.g. decision-making, effective 
communication, disclosure). 
4.29 b 
Hospital pharmacists can build long-term relationships with young people and families. 4.14 b 
Hospital pharmacists do continuing professional development sessions for community 
pharmacists about JIA medicines. 
4.11 
Pharmacists support transition services for young people going into adult rheumatology care. 4.00 b 
Pharmacists develop better skills in communicating with young people and parents. 3.89 
Rheumatology team members do continuing professional development sessions for 
community pharmacists about JIA medicines. 
3.88 a 
Pharmacists work with home delivery companies to optimize medication supply. 3.78 
Pharmacists are advocates for young people with JIA and challenge prescribing decisions. 3.75 a 
Pharmacists can be directly available to young people and parents/carers by email or 
telephone. 
3.71b 
Hospital pharmacists can do clinics in the hospital for young people with JIA. 3.67 
Young people with JIA carry a card to signal their condition and their ability to collect their 
own prescriptions. 
3.63a 
Pharmacists do medication review for young people with JIA. 3.56 
Pharmacists need to develop better skills in confidentiality and consent for young people. 3.22 
Pharmacists need to develop better skills in safeguarding for young people. 3.11 
Community pharmacists co-ordinate supply of JIA medication for young people. 2.89 
Hospital pharmacists do clinics in the community for young people with JIA. 2.22 
Priority mean scores are reported to 2 decimal places – data averaged from 9 multidisciplinary groups. 
a = 8 groups; b = 7 groups - some groups did not complete ranking for all roles. 
1 was low priority for future development and 5 was high. 
